Chris Froome dealt blow by UKAD data

Chris Froome dealt blow by UKAD data

Joe Robinson 1 Mar 2018 Latest information from UKAD contradicts Dave Brailsford claims, dealing blow to Froome's potential defence New information surrounding the on-going Chris Froome salbutamol case could deal a major blow to his expected defence. A Freedom of Information request by the Press Association revealed that all three adverse analytical findings for salbutamol dealt with by UK Anti-Doping between January 2015 and December 2017 led to anti-doping rule violation cases. It also showed that within this 36 month period, salbutamol cases counted for just three of all 109 adverse analytical findings with all cases for the asthma drug leading to subsequent cases. The data also told that bans had been handed in other sports of the presence of salbutamol in their urine. These facts contradict the words of Team Sky manager Dave Brailsford at last month's Ruta del Sol and will likely land a blow to expected defence ...

Read on Cyclist


More Like This

Card image cap

UK Anti-Doping data a blow to Chris Froome's salbutamol defence

View
Card image cap

Brailsford: I'm constantly thinking, 'Am I the right person to support the team?'

View
Card image cap

A ‘staggering report’ and the future of Sky

View
Card image cap

ASO moving to block Chris Froome's Tour de France defence

View
Card image cap

Testosterone order to British Cycling could have been intentional

View
Card image cap

What the newest salbutamol study means for Froome

View
Card image cap

Wiggins, Brailsford and Sky rocked by report into TUEs and corticosteroid use

View
Card image cap

UCI corrects race director’s assurance that Froome’s Giro result will stand

View
Card image cap

Lappartient: Chris Froome's case will not be resolved before the Giro d'Italia

View
Card image cap

Ukad had three adverse findings for Salbutamol in three years and all led to doping charges

View